Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 711: What is the drug of choice for Pseudomonas septicemia?

A. Methicillin
B. Ceftazidime
C. Moxalactam
D. Piperacillin (Correct Answer)

Explanation: **Explanation:** **Piperacillin** is a broad-spectrum, extended-spectrum penicillin (Antipseudomonal penicillin) and is considered a first-line drug of choice for serious infections caused by *Pseudomonas aeruginosa*, including septicemia. Its mechanism involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). In clinical practice, it is almost always used in combination with a beta-lactamase inhibitor (Tazobactam) to enhance its spectrum and prevent resistance. **Analysis of Options:** * **A. Methicillin:** This is a penicillinase-resistant penicillin primarily used against *Staphylococcus aureus*. It has no activity against Gram-negative organisms like *Pseudomonas*. * **B. Ceftazidime:** While Ceftazidime is a 3rd generation cephalosporin with excellent anti-pseudomonal activity, Piperacillin (especially when combined with an aminoglycoside or tazobactam) remains the traditional gold standard for systemic pseudomonal sepsis in many standardized examinations. * **C. Moxalactam:** This is an older oxacephem antibiotic. While it has some Gram-negative activity, it is rarely used today due to significant side effects, including interference with vitamin K metabolism and platelet dysfunction (bleeding diathesis). **High-Yield Clinical Pearls for NEET-PG:** * **Antipseudomonal Penicillins:** These include Carboxypenicillins (Ticarcillin, Carbenicillin) and Ureidopenicillins (Piperacillin, Mezlocillin). Piperacillin is the most potent among them. * **Synergy:** For *Pseudomonas* septicemia, a combination of an antipseudomonal beta-lactam and an **Aminoglycoside** (like Amikacin or Tobramycin) is often used to achieve synergistic killing and prevent the emergence of resistance. * **Other Antipseudomonal Cephalosporins:** Apart from Ceftazidime, **Cefepime** (4th gen) and **Ceftolozane** (5th gen) also cover *Pseudomonas*.

Question 712: An HIV patient presented with diarrhea. On stool examination, acid-fast organisms were seen. What is the drug of choice for this patient?

A. TMP-SMX (Correct Answer)
B. Nitazoxanide
C. Primaquine
D. Niclosamide

Explanation: ### Explanation **1. Understanding the Diagnosis** In an HIV-positive patient presenting with diarrhea, the presence of **acid-fast organisms** on stool examination (Modified Acid-Fast/Kinyoun stain) is pathognomonic for Coccidian parasites. The three primary culprits are: * ***Cystoisospora belli* (formerly *Isospora belli*):** Large, oval oocysts. * ***Cyclospora cayetanensis*:** Spherical oocysts. * ***Cryptosporidium hominis/parvum*:** Small, round oocysts. Among these, **TMP-SMX (Trimethoprim-Sulfamethoxazole)** is the definitive drug of choice for both ***Cystoisospora belli*** and ***Cyclospora***. While *Cryptosporidium* is also acid-fast, it is typically treated with Nitazoxanide; however, in the context of standard NEET-PG patterns, "Acid-fast + HIV + Diarrhea" most frequently points toward *Cystoisospora*, making TMP-SMX the best answer. **2. Analysis of Incorrect Options** * **B. Nitazoxanide:** This is the drug of choice for *Cryptosporidium* in immunocompetent patients and for *Giardia*. In HIV patients, its efficacy is limited without immune reconstitution (ART). * **C. Primaquine:** Used for the radical cure of *P. vivax* malaria and as a secondary treatment for *Pneumocystis jirovecii* (combined with Clindamycin). It has no role in treating acid-fast protozoa. * **D. Niclosamide:** The drug of choice for tapeworm infections (Cestodes) like *Taenia solium* and *Diphyllobothrium latum*. It is not effective against protozoal diarrhea. **3. High-Yield Clinical Pearls for NEET-PG** * **Size Matters:** If the oocyst is **4–6 µm**, think *Cryptosporidium*; if it is **8–10 µm**, think *Cyclospora*; if it is large and **ellipsoid (20–30 µm)**, it is *Cystoisospora*. * **Prophylaxis:** TMP-SMX used for *Pneumocystis jirovecii* (PJP) prophylaxis in HIV patients also provides cross-protection against *Cystoisospora*. * **Alternative:** For patients allergic to Sulfa drugs, **Pyrimethamine** is the alternative for *Cystoisospora*.

Question 713: Which of the following drugs is effective against HIV with Y181C mutation?

A. Festinavir
B. Lersivirine (Correct Answer)
C. Elvitegravir
D. Dolutegravir

Explanation: **Explanation:** The **Y181C mutation** is a common resistance-associated mutation in HIV-1 that significantly reduces the efficacy of first-generation Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) like Nevirapine and Efavirenz. **1. Why Lersivirine is correct:** **Lersivirine** is a next-generation (second-generation) NNRTI. Unlike first-generation agents, second-generation NNRTIs are designed with structural flexibility (molecular torsional freedom), allowing them to bind effectively to the reverse transcriptase enzyme even in the presence of common mutations like **Y181C** and **K103N**. This makes them potent against resistant strains of HIV. **2. Why the other options are incorrect:** * **Festinavir (A):** This is an experimental Nucleoside Reverse Transcriptase Inhibitor (NRTI), specifically a thymidine analogue. It belongs to a different class and is not the primary choice for overcoming specific NNRTI-associated mutations like Y181C. * **Elvitegravir (C) & Dolutegravir (D):** These drugs belong to the **INSTI (Integrase Strand Transfer Inhibitor)** class. They inhibit the viral integrase enzyme, not reverse transcriptase. While they are used in salvage therapy, the Y181C mutation specifically affects NNRTI binding, making an "advanced NNRTI" like Lersivirine the specific pharmacological answer for this mutation. **High-Yield Clinical Pearls for NEET-PG:** * **First-gen NNRTIs:** Nevirapine, Efavirenz (Low genetic barrier; susceptible to K103N/Y181C). * **Second-gen NNRTIs:** Etravirine, Rilpivirine, Lersivirine, Doravirine (Effective against resistant strains). * **K103N:** The most common mutation causing resistance to Efavirenz. * **Y181C:** Specifically confers high-level resistance to Nevirapine and moderate resistance to Efavirenz.

Question 714: Extended activity of beta-lactamases inactivates which class of antibiotics?

A. Cephalosporins (3rd generation) (Correct Answer)
B. Macrolides
C. Quinolones
D. Aminoglycosides

Explanation: ### Explanation **1. Why Cephalosporins (3rd generation) is correct:** Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes produced by certain bacteria (most commonly *E. coli* and *Klebsiella*) that mediate resistance by hydrolyzing the beta-lactam ring. While classic beta-lactamases (like penicillinase) only target penicillins, **ESBLs** have an "extended" range of activity. They specifically inactivate **3rd-generation cephalosporins** (e.g., Ceftriaxone, Cefotaxime, Ceftazidime) and monobactams (Aztreonam). This is a critical clinical distinction because these drugs are often the first-line treatment for serious gram-negative infections. **2. Why the other options are incorrect:** * **B. Macrolides (e.g., Azithromycin):** These inhibit protein synthesis by binding to the 50S ribosomal subunit. They do not contain a beta-lactam ring; therefore, beta-lactamase enzymes have no effect on them. * **C. Quinolones (e.g., Ciprofloxacin):** These inhibit DNA synthesis by targeting DNA gyrase and Topoisomerase IV. Resistance is typically due to mutations in target enzymes or efflux pumps, not enzymatic degradation by beta-lactamases. * **D. Aminoglycosides (e.g., Gentamicin):** These inhibit protein synthesis by binding to the 30S ribosomal subunit. Resistance is primarily mediated by **Aminoglycoside Modifying Enzymes (AMEs)**, not beta-lactamases. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For infections caused by ESBL-producing organisms, **Carbapenems** (e.g., Meropenem, Imipenem) are the treatment of choice, as they remain stable against ESBL hydrolysis. * **Inhibitor Sensitivity:** ESBLs are typically inhibited by beta-lactamase inhibitors like **Clavulanic acid**, Sulbactam, and Tazobactam. * **Marker:** In the lab, resistance to **Ceftazidime** is often used as a screening marker for ESBL production. * **Cefepime (4th Gen):** While 4th-generation cephalosporins have some stability, they are generally not recommended for serious ESBL infections.

Question 715: What is the most effective drug against extracellular mycobacteria?

A. Isoniazid
B. Rifampicin (Correct Answer)
C. Pyrazinamide
D. Ethambutol

Explanation: **Explanation:** Mycobacterium tuberculosis exists in different metabolic states within the host. To achieve a complete cure, drugs must target these specific subpopulations. **1. Why Rifampicin is the correct answer:** Mycobacteria are classified into four populations based on their location and metabolic activity. The **extracellular population** (found in the walls of aerobic cavitary lesions) is the largest, most rapidly multiplying, and most prone to developing drug resistance. **Rifampicin** is the most potent bactericidal drug against these rapidly dividing extracellular bacilli. While Isoniazid is also bactericidal, Rifampicin’s ability to inhibit RNA synthesis makes it exceptionally effective across all populations, including those with intermittent metabolic activity. **2. Analysis of Incorrect Options:** * **Isoniazid (INH):** While highly bactericidal against rapidly dividing bacilli, it is traditionally considered slightly less effective than Rifampicin in the overall sterilization of extracellular cavitary loads. * **Pyrazinamide:** This drug is specifically active against **intracellular** mycobacteria residing within acidic environments (macrophages). It is ineffective at the neutral pH found in extracellular lesions. * **Ethambutol:** This is a **bacteriostatic** drug. Its primary role is to inhibit cell wall synthesis and prevent the emergence of resistance to more potent drugs; it is not the "most effective" killer of any subpopulation. **NEET-PG High-Yield Pearls:** * **Best Sterilizing Agent:** Rifampicin (kills "persisters" or spurters). * **Best for Acidic pH/Intracellular:** Pyrazinamide. * **Fastest Sputum Conversion:** Isoniazid (due to high early bactericidal activity). * **Visual Side Effects:** Ethambutol (Optic neuritis – check visual acuity and red-green color vision). * **Mnemonic for Populations:** * **R**ifampicin: **R**apidly dividing (Extracellular). * **P**yrazinamide: **P**hagocytes (Intracellular/Acidic).

Question 716: What property should drugs used in neutropenic patients possess?

A. Bactericidal (Correct Answer)
B. Bacteriostatic
C. Highly potent
D. Administered via IV route

Explanation: **Explanation:** In patients with **neutropenia** (absolute neutrophil count <500 cells/mm³), the body’s primary defense mechanism—the phagocytic action of white blood cells—is severely compromised. 1. **Why Bactericidal is correct:** Bacteriostatic drugs only inhibit the growth and replication of bacteria, relying entirely on the host’s immune system (neutrophils and macrophages) to ultimately kill and clear the "arrested" pathogens. In a neutropenic patient, this clearance cannot occur, leading to treatment failure or relapse once the drug is stopped. **Bactericidal drugs**, however, kill the bacteria directly regardless of the host's immune status, making them mandatory in immunocompromised states. 2. **Why other options are incorrect:** * **Bacteriostatic:** As explained, these require an intact immune system to be effective. * **Highly potent:** While potency (the dose required to produce an effect) is a pharmacological property, it does not guarantee the eradication of bacteria in the absence of immune cells. A drug can be highly potent but still only bacteriostatic (e.g., Tigecycline). * **Administered via IV route:** While many drugs for febrile neutropenia are given IV for rapid bioavailability, the *pharmacodynamic* property (killing vs. inhibiting) is more critical than the route of administration itself. **Clinical Pearls for NEET-PG:** * **Mnemonic for Bactericidal drugs:** "**V**ery **F**inely **P**enicillins **A**nd **A**minoglycosides **C**ause **B**acterial **D**eath" (**V**ancomycin, **F**luoroquinolones, **P**enicillins/Cephalosporins, **A**minoglycosides, **A**zithromycin (only at high doses), **C**otrimoxazole, **B**acitracin, **D**aptomycin). * **Empiric Therapy:** In febrile neutropenia, the initial choice is usually a bactericidal antipseudomonal beta-lactam (e.g., Piperacillin-Tazobactam or Cefepime).

Question 717: Which of the following is NOT a known side effect of quinine?

A. Causes hypotension
B. Acts as a local irritant
C. Causes hyperglycemia (Correct Answer)
D. Decreases skeletal muscle contraction

Explanation: **Explanation:** **Quinine**, a cinchona alkaloid used primarily for chloroquine-resistant malaria, is known for its narrow therapeutic index and specific metabolic effects. **Why Option C is correct:** Quinine does **not** cause hyperglycemia; instead, it is a potent stimulator of pancreatic beta cells, leading to hyperinsulinemia. This results in **hypoglycemia**, which can be severe and life-threatening, especially in pregnant patients or those with severe malaria. Monitoring blood glucose is mandatory during quinine therapy. **Why the other options are incorrect:** * **Option A (Hypotension):** When administered via rapid intravenous injection, quinine causes peripheral vasodilation and myocardial depression, leading to significant hypotension. It should always be given as a slow infusion. * **Option B (Local Irritant):** Quinine is highly acidic and acts as a potent local irritant. It can cause sterile abscesses if given intramuscularly and thrombophlebitis when administered intravenously. * **Option C (Decreases skeletal muscle contraction):** Quinine increases the refractory period of the motor endplate and reduces the response to nerve stimulation. This property is utilized clinically to treat nocturnal leg cramps. **High-Yield NEET-PG Pearls:** 1. **Cinchonism:** A classic triad of toxicity involving tinnitus, high-frequency hearing loss, and dizziness/headache. 2. **Blackwater Fever:** A rare but fatal complication involving massive hemolysis and hemoglobinuria. 3. **ECG Changes:** Quinine can cause QT interval prolongation (risk of Torsades de Pointes). 4. **Contraindication:** It is contraindicated in patients with Myasthenia Gravis due to its neuromuscular blocking effects.

Question 718: What is the drug of choice for treating liver fluke infections?

A. Mebendazole
B. Ivermectin
C. Triclobendazole (Correct Answer)
D. Praziquantel

Explanation: ### Explanation **Correct Answer: C. Triclobendazole** **Why it is correct:** Liver fluke infections are primarily caused by *Fasciola hepatica* and *Fasciola gigantica*. **Triclobendazole** is the drug of choice (DOC) for fascioliasis. Unlike other trematodes, *Fasciola* species are uniquely resistant to Praziquantel because their tegument structure differs. Triclobendazole works by binding to beta-tubulin, preventing the polymerization of microtubules, which leads to the disruption of the fluke's surface and metabolic inhibition. It is highly effective against both adult and immature flukes. **Analysis of Incorrect Options:** * **A. Mebendazole:** This is a broad-spectrum benzimidazole used primarily for intestinal nematodes (Roundworm, Whipworm, Hookworm). It is not effective against liver flukes. * **B. Ivermectin:** This is the DOC for Strongyloidiasis and Onchocerciasis (River Blindness). It acts on glutamate-gated chloride channels, which are not the primary targets in trematodes like *Fasciola*. * **D. Praziquantel:** While Praziquantel is the DOC for almost all other trematode (fluke) infections—including Schistosomiasis, Clonorchiasis, and Opisthorchiasis—it is **ineffective** against *Fasciola hepatica*. **High-Yield Clinical Pearls for NEET-PG:** * **Fascioliasis:** DOC is Triclobendazole. * **Clonorchiasis/Opisthorchiasis (Chinese Liver Fluke):** DOC is Praziquantel (Note: These are also "liver flukes" but have different drug sensitivities than *Fasciola*). * **Hydatid Cyst (*E. granulosus*):** DOC is Albendazole. * **Neurocysticercosis:** Albendazole is preferred over Praziquantel due to better CNS penetration and efficacy against viable cysts. * **Strongyloidiasis:** Ivermectin is the DOC.

Question 719: Which of the following is an indication for rilpivirine?

A. HIV (Correct Answer)
B. Hepatitis C
C. Hepatitis B
D. Influenza A

Explanation: **Explanation:** **Rilpivirine** is a second-generation **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)** used in the management of **HIV-1 infection**. ### 1. Why HIV is Correct Rilpivirine works by binding non-competitively to the HIV-1 reverse transcriptase enzyme, causing a conformational change in the active site that inhibits viral DNA synthesis. As a second-generation NNRTI, it offers several advantages over first-generation drugs like Efavirenz, including a higher genetic barrier to resistance, a longer half-life, and a significantly better neuropsychiatric side-effect profile. It is typically used in treatment-naïve patients with a viral load <100,000 copies/mL. ### 2. Why Other Options are Incorrect * **Hepatitis C:** Treated with Direct-Acting Antivirals (DAAs) such as Sofosbuvir, Ledipasvir, or Velpatasvir. * **Hepatitis B:** Managed with Nucleoside/Nucleotide analogues (e.g., Tenofovir, Entecavir) or Interferon-alpha. * **Influenza A:** Treated with neuraminidase inhibitors (Oseltamivir) or M2 ion channel blockers (Amantadine). ### 3. High-Yield Clinical Pearls for NEET-PG * **Administration:** Rilpivirine requires an **acidic gastric environment** for absorption. Therefore, it is contraindicated with Proton Pump Inhibitors (PPIs). It must be taken with a **high-calorie meal**. * **Long-acting Formulation:** Cabotegravir + Rilpivirine is available as a monthly or bi-monthly intramuscular injection for maintenance therapy in virologically suppressed patients. * **Side Effects:** While better tolerated than Efavirenz, it can still cause depression, insomnia, and QT prolongation at high doses. * **NNRTI Class Members:** Remember the mnemonic **"DEN"** for common NNRTIs: **D**elavirdine, **E**favirenz, **N**evirapine, and the newer agents **Etravirine** and **Rilpivirine**.

Question 720: Which of the following drugs requires dose adjustment in renal failure?

A. Cefoperazone
B. Doxycycline
C. Streptomycin (Correct Answer)
D. Rifampicin

Explanation: **Explanation:** The correct answer is **Streptomycin**. The fundamental principle governing dose adjustment in renal failure is the route of elimination. Drugs primarily excreted unchanged by the kidneys require dose reduction or interval extension to prevent systemic toxicity. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside**. All aminoglycosides are highly polar, water-soluble molecules that are excreted almost entirely (90%+) by glomerular filtration in an unchanged form. In renal impairment, their clearance decreases proportionately with the Creatinine Clearance (CrCl). Failure to adjust the dose leads to accumulation, significantly increasing the risk of **ototoxicity** and **nephrotoxicity**. **2. Why the other options are incorrect:** * **Cefoperazone:** Unlike most Cephalosporins, Cefoperazone (and Ceftriaxone) is primarily excreted through the **biliary system**. Therefore, it is safe to use in renal failure without dose adjustment. * **Doxycycline:** This is a unique Tetracycline. It is excreted into the gut lumen via chelation and eliminated in feces. It does not accumulate in the blood even in end-stage renal disease, making it the **Tetracycline of choice in renal failure**. * **Rifampicin:** This drug undergoes extensive **hepatic metabolism** and is excreted mainly through bile. It does not require dose modification in patients with renal impairment. **High-Yield Clinical Pearls for NEET-PG:** * **"Safe" Antimicrobials in Renal Failure (No dose adjustment):** Ceftriaxone, Cefoperazone, Doxycycline, Rifampicin, Erythromycin, Clindamycin, and Linezolid. * **Aminoglycoside Monitoring:** In renal failure, the "Rule of Thumb" is to increase the dosing interval rather than just decreasing the dose to maintain peak efficacy (Concentration-dependent killing). * **Anti-TB Drugs:** Among first-line anti-TB drugs, **Ethambutol** and **Pyrazinamide** require the most careful adjustment in renal failure, whereas Rifampicin and Isoniazid are relatively safe.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free